Evidence map›Paper›PMID 39587848›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

H. Pylori-Facilitated TERT/Wnt/β-Catenin Triggers Spasmolytic Polypeptide-Expressing Metaplasia and Oxyntic Atrophy.

Lijiao He, Xiao Zhang, Shengwei Zhang, Yi Wang, Weichao Hu, Jie Li, Yunyi Liu, Yu Liao, Xue Peng, Jianjun Li and 5 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. EradicatingBioactive materials · 2026
    Article
  3. Review
  4. Article
  5. Recent advances in spasmolytic polypeptide expressing metaplasia research.World journal of gastrointestinal oncology · 2026
    Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Lijiao HeDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Xiao ZhangDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Shengwei ZhangDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Yi WangDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Weichao HuDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Jie LiDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Yunyi LiuDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Yu LiaoDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Xue PengDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Jianjun LiDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Haiyan ZhaoDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Liting WangDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Yang-Fan LvDepartment of Pathology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Chang-Jiang HuDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.
Shi-Ming YangDepartment of Gastroenterology, The Second Affiliated Hospital of Army Medical University, Chongqing, 400037, China.ORCID 0000-0002-0000-4795

Funding

Key Program of Natural Science Foundation of Chongqing cstc2020jcyj-zdxmX0020Key Program of the 987th Hospital 2024Djbqyy-06National Natural Science Foundation of China 82200627Outstanding Youth Fund of Chongqing cstc2021jcyj-jqX0035Talent Project of the Second Affiliated Hospital of the Army Medical University 2022XKRC005
6 · The paper itself

Abstract

Persistent H. pylori infection triggers the repair program of the mucosa, such as spasmolytic polypeptide-expressing metaplasia (SPEM). However, the mechanism underlying the initiation of SPEM in gastric tissues by H. pylori remains unclear. Here, an increase in telomerase reverse transcriptase (TERT) protein expression is observed in chief cells upon infection with cagA-positive H. pylori. Tert knockout significantly ameliorated H. pylori-induced SPEM and single-cell RNA sequencing demonstrated that the Wnt/β-Catenin pathway is suppressed in gastric cells with Tert knockout. Mechanism study revealed that CagA elevated TERT abundance by disrupting the interaction between TERT and its novel E3 ligase, SYVN1. Interestingly, Nitazoxanide effectively relieved SPEM via inhibition of the Wnt/β-Catenin signaling in vivo. This results clarified the mechanism underlying which CagA activated the TERT/Wnt/β-Catenin pathway, thus promoting the dedifferentiation of chief cells and the occurrence of SPEM in gastric mucosa. This highlights a molecular basis for targeting CagA-activated Wnt signaling in chief cells for the treatment of gastric precancerous lesions.

Indexed as

Helicobacter InfectionsHelicobacter pyloriPeptidesTelomeraseAnimalsAntigens, BacterialAtrophyBacterial Proteinsbeta CateninGastric MucosaHumansIntercellular Signaling Peptides and ProteinsMetaplasiaMiceWnt Signaling PathwayAntigens, BacterialBacterial Proteinsbeta CateninIntercellular Signaling Peptides and ProteinsPeptidesspasmolytic polypeptideTelomeraseTERT protein, humanCagAH. pylori infectionnitazoxanideSPEMTERT

Identifiers

PMID39587848
PMCPMC11744579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.